gen0101
Biologicalexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2015 (NCT02502994)
Timeline
Indications
Mechanism of action
- Oncolytic virusOTHER
Oncolytic virus other
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gen0101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03818893 | Phase 2 | Mar 31, 2019 | Ishihara Sangyo Kaisha, Ltd., Merck, Osaka University |
| NCT02502994 | Phase 1 | May 1, 2015 | Osaka University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Osaka University | Academic/Hospital | 2 | 2 | 2 | 2015 |
| Ishihara Sangyo Kaisha, Ltd. | For profit | 1 | 0 | 1 | 2019 |
| Merck | For profit | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1